Publication date: Aug 08, 2019
Variable, glutamine-encoding, CAA interruptions indicate that a property of the uninterrupted HTT CAG repeat sequence, distinct from the length of huntingtin’s polyglutamine segment, dictates the rate at which Huntington’s disease (HD) develops. The timing of onset shows no significant association with HTT cis-eQTLs but is influenced, sometimes in a sex-specific manner, by polymorphic variation at multiple DNA maintenance genes, suggesting that the special onset-determining property of the uninterrupted CAG repeat is a propensity for length instability that leads to its somatic expansion. Additional naturally occurring genetic modifier loci, defined by GWAS, may influence HD pathogenesis through other mechanisms. These findings have profound implications for the pathogenesis of HD and other repeat diseases and question the fundamental premise that polyglutamine length determines the rate of pathogenesis in the “polyglutamine disorders.”
email@example.com, Genetic Modifiers. of. Huntington’s. Disease. (GeM-HD). Consortium.. Electronic. address:. and Consortium, Genetic Modifiers. of. Huntington’s. Disease. (GeM-HD). CAG Repeat Not Polyglutamine Length Determines Timing of Huntington’s Disease Onset. 06622. 2019 Cell (178):4.
|Huntingtin||Trinucleotide repeat disorder|
|Huntington||Branches of biology|
- Insights on timing of Huntington’s Disease onset
- Glycation in Huntington’s Disease: A Possible Modifier and Target for Intervention.
- Quality Control in Huntington’s Disease: a Therapeutic Target.